Optimal controls for a mathematical model of tumor-immune interactions under targeted chemotherapy with immune boost

DOI10.3934/DCDSB.2013.18.1031zbMath1275.49036OpenAlexW1977373484MaRDI QIDQ378951

Mozhdeh Sadat Faraji Mosalman, Heinz Schättler, Urszula Łedzewicz-Kowalewska

Publication date: 12 November 2013

Published in: Discrete and Continuous Dynamical Systems. Series B (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.3934/dcdsb.2013.18.1031

zbMATH Keywords

optimal control singular controls chemotherapy regions of attraction tumor-immune interactions

Mathematics Subject Classification ID

Applications of optimal control and differential games (49N90) Application models in control theory (93C95) Medical applications (general) (92C50) Optimality conditions for problems involving ordinary differential equations (49K15)

Related Items (13)

Dynamical properties of a minimally parameterized mathematical model for metronomic chemotherapy ⋮ Optimal control of vibration-based micro-energy harvesters ⋮ Optimal Control of Cancer Treatments: Mathematical Models for the Tumor Microenvironment ⋮ Metaheuristics and Pontryagin's minimum principle for optimal therapeutic protocols in cancer immunotherapy: a case study and methods comparison ⋮ On the optimal control problem for a model of the synergy of chemo‐ and immunotherapy ⋮ On modeling the synergy of cancer immunotherapy with radiotherapy ⋮ Bang-bang optimal controls for a mathematical model of chemo- and immunotherapy in cancer ⋮ Fastest time to cancer by loss of tumor suppressor genes ⋮ On the role of the objective in the optimization of compartmental models for biomedical therapies ⋮ Optimization of combination therapy for chronic myeloid leukemia with dosing constraints ⋮ Therapy strategy in tumour cells and immune system interaction mathematical model ⋮ On the role of tumor heterogeneity for optimal cancer chemotherapy ⋮ Analysis of a cancer dormancy model and control of immuno-therapy

This page was built for publication: Optimal controls for a mathematical model of tumor-immune interactions under targeted chemotherapy with immune boost